CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...